Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Mahr

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Rheumatology (Oxford, England)|January 25, 2011
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnessesCecile Marchand-Janssen, Pierre Loulergue, Luc Mouthon, et al.
Arthritis and Rheumatism|February 13, 2003
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patientsLoïc Guillevin, Pascal Cohen, Alfred Mahr, et al.
BMJ Open|February 26, 2022
Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic reviewYingqi Xiao, Gordon Guyatt, Linan Zeng, et al.
Orphanet Journal of Rare Diseases|February 24, 2021
French recommendations for the management of Behçet's diseaseIsabelle Kone-Paut, Stéphane Barete, Bahram Bodaghi, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
The Journal of Rheumatology|February 19, 2013
Influence of environmental factors on disease activity in spondyloarthritis: a prospective cohort studyNadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, et al.
Seminars in Arthritis and Rheumatism|July 18, 2021
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020Kaitlin A Quinn, Sara Monti, Robin Christensen, et al.
JAMA|November 10, 2010
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trialThomas F Hiemstra, Michael Walsh, Alfred Mahr, et al.
Annals of the Rheumatic Diseases|November 27, 2010
Long-term patient survival in ANCA-associated vasculitisOliver Flossmann, Annelies Berden, Kirsten de Groot, et al.
Journal of the American College of Cardiology|January 10, 2015
Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Tomasz Miszalski-Jamka, Wojciech Szczeklik, Barbara Sokołowska, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Rheumatology (Oxford, England)|January 25, 2011
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnessesCecile Marchand-Janssen, Pierre Loulergue, Luc Mouthon, et al.
Arthritis and Rheumatism|February 13, 2003
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patientsLoïc Guillevin, Pascal Cohen, Alfred Mahr, et al.
BMJ Open|February 26, 2022
Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic reviewYingqi Xiao, Gordon Guyatt, Linan Zeng, et al.
Orphanet Journal of Rare Diseases|February 24, 2021
French recommendations for the management of Behçet's diseaseIsabelle Kone-Paut, Stéphane Barete, Bahram Bodaghi, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
The Journal of Rheumatology|February 19, 2013
Influence of environmental factors on disease activity in spondyloarthritis: a prospective cohort studyNadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, et al.
Seminars in Arthritis and Rheumatism|July 18, 2021
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020Kaitlin A Quinn, Sara Monti, Robin Christensen, et al.
JAMA|November 10, 2010
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trialThomas F Hiemstra, Michael Walsh, Alfred Mahr, et al.
Annals of the Rheumatic Diseases|November 27, 2010
Long-term patient survival in ANCA-associated vasculitisOliver Flossmann, Annelies Berden, Kirsten de Groot, et al.
Journal of the American College of Cardiology|January 10, 2015
Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Tomasz Miszalski-Jamka, Wojciech Szczeklik, Barbara Sokołowska, et al.
Pageof 16